Tekla Life Sciences Investors invests primarily in biotechnology stocks, and 10-12 large-cap biotech stocks (50% of total holdings) sets the trend and price direction for this fund. Poor price growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback